Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, and Pharmacokinetic Profile of ANB020 Administered to Adult Subjects With Moderate-to-Severe Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 May 2023
Price :
$35
*
At a glance
- Drugs Etokimab (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Therapeutic Use
- Acronyms ATLAS
- Sponsors AnaptysBio
- 26 Apr 2023 Status changed from discontinued to completed.
- 12 Jul 2020 This trial has been completed in United Kingdom, according to European Clinical Trials Database record.
- 03 Jul 2020 This trial has been completed in Czech Republic , according to European Clinical Trials Database record.